Top Markets
#1 Black Phoenix Black Phoenix +732.34%
#2 MiL.k Alliance MiL.k Alliance +26.75%
#3 Biconomy Biconomy +25.03%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.00%
#5 THORChain THORChain +19.41%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +15.57%
#7 Tokamak Network Tokamak Network +15.53%
#8 THORChain Yield THORChain Yield +14.29%
#9 Moolah Moolah +14.06%
#10 The Black Bull The Black Bull +12.36%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Mirati Therapeutics, Inc. Mirati Therapeutics, Inc.

Mirati Therapeutics, Inc.

MRTX
Rang in Aktien #5115
Mirati Therapeutics, Inc. is a U.S.-based biotechnology firm operating at the... Mirati Therapeutics, Inc. is a U.S.-based biotechnology firm operating at the clinical stage, committed to identifying and developing treatments that target the genetic and immunological factors driving cancer progression. Its pipeline features MRTX849, a KRAS G12C inhibitor currently undergoing Phase 1/2 clinical trials for a range of malignancies, including non-small cell lung, colorectal, and pancreatic cancers. Additionally, the company is advancing Sitravatinib, an investigational broad-spectrum kinase inhibitor, which has reached Phase 3 clinical trials specifically for non-small cell lung cancer. Mirati also has a KRAS G12D inhibitor program in its preclinical development phase. The company has forged a collaboration and licensing agreement with BeiGene, Ltd. for the development, manufacturing, and commercialization of sitravatinib. Established in 1995, Mirati Therapeutics, Inc. maintains its headquarters in San Diego, California.
Aktienkurs
$58.70
Zuletzt synchronisiert: 2024-01-23
Marktkapitalisierung
$2.98B
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Mirati Therapeutics, Inc. (MRTX)

Kategorie

Healthcare
Kursverlauf für Mirati Therapeutics, Inc. (MRTX)
Höchster Schlusskurs: $58.94 am 2024-01-01

Niedrigster Schlusskurs: $8.67 am 2013-07-01
Kursverlauf der Aktie von Mirati Therapeutics, Inc. von 2013 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2024 2.02%
2023 12.06%
2022 -63.56%
2021 -39.15%
2020 103.16%
2019 189.49%
2018 132.29%
2017 218.41%
2016 -84.08%
2015 98.82%
2014 1.02%
2013 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $549.38 41.20%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 47.75%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $148.35 491.02%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.50 -12.74%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $764.47 7.08%
CH